NASDAQ : UTMD
Utah Medical Products, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 66.8 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 212.09M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 216.14M |
| Enterprise Value | 131.12M |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 22, 2026 |
| Ex-Dividend Date | Sep 17, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 3.18M |
| Shares Outstanding | 3.18M |
| Shares Change (YoY) | -3.07% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 7.22% |
| Owned by Institutions (%) | 69.98% |
| Float | 2.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 20.39 |
| Forward PE | n/a |
| PS Ratio | 6.19 |
| Forward PS | n/a |
| PB Ratio | 1.75 |
| P/TBV Ratio | 2.05 |
| P/FCF Ratio | 18.88 |
| P/OCF Ratio | 18.24 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 12.32 |
| EV / Sales | 3.75 |
| EV / EBITDA | 9.79 |
| EV / EBIT | 10.96 |
| EV / FCF | 11.45 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 21.23 |
| Quick Ratio | 18.81 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.81% |
| Return on Assets (ROA) | 5.97% |
| Return on Invested Capital (ROIC) | 26.90% |
| Return on Capital Employed (ROCE) | 9.67% |
| Weighted Average Cost of Capital (WACC) | 6.37% |
| Revenue Per Employee | $229,724 |
| Profits Per Employee | $70,020 |
| Employee Count | 152 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 1.58 |
Taxes
| Measure | Value |
|---|
| Income Tax | 2.33M |
| Effective Tax Rate | 17.98% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +19.39% |
| 50-Day Moving Average | 72.90 |
| 200-Day Moving Average | 68.07 |
| Relative Strength Index (RSI) | 30.12 |
| Average Volume (20 Days) | 42,033 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 140,215 |
| Short Previous Month | 151,912 |
| Short % of Shares Out | 4.42% |
| Short % of Float | 5.06% |
| Short Ratio (days to cover) | 3.76 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 34.92M |
| Gross Profit | 20.14M |
| Operating Income | 11.97M |
| Pretax Income | 12.98M |
| Net Income | 10.64M |
| EBITDA | 13.39M |
| EBIT | 11.97M |
| Earnings Per Share (EPS) | $3.34 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 85.20M |
| Total Debt | 180,000 |
| Net Cash | 85.02M |
| Net Cash Per Share | $26.78 |
| Equity (Book Value) | 123.28M |
| Book Value Per Share | 38.83 |
| Working Capital | 95.89M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 11.85M |
| Capital Expenditures | -400,000 |
| Depreciation & Amortization | 1.42M |
| Net Borrowing | n/a |
| Free Cash Flow | 11.45M |
| FCF Per Share | $3.61 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.69% |
| Operating Margin | 34.27% |
| Pretax Margin | 37.16% |
| Profit Margin | 30.48% |
| EBITDA Margin | 38.34% |
| EBIT Margin | 34.27% |
| FCF Margin | 31.70% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.24 |
| Dividend Yield | 1.82% |
| Dividend Growth (YoY) | 1.64% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 37.14% |
| FCF Payout Ratio | 34.39% |
| Buyback Yield | 3.07% |
| Shareholder Yield | 4.89% |
| Earnings Yield | 4.90% |
| FCF Yield | 5.30% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Mar 22, 1993 |
| Split Type | Forward |
| Split Ratio | 1.5:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |